CIK 0001671927 · Large accelerated filer
Immunocore Holdings plc
Sign in to watch- Ticker
- IMCR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 01235 5430281
- Business address
- 90 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom, OX14 4RY
- Former names
- Immunocore Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-17 | Jallal Bahija CHIEF EXECUTIVE OFFICER | Option exercise | +23,817 | 23,817 | ||
| 2026-02-17 | Jallal Bahija CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Share Units | −23,817 | 71,453 | ||
| 2026-02-17 | Jallal Bahija CHIEF EXECUTIVE OFFICER | Grant or award · Restricted Share Units | +88,573 | 88,573 | ||
| 2026-02-17 | Jallal Bahija CHIEF EXECUTIVE OFFICER | Grant or award · Employee Share Option (Right to Buy) | +395,066 | 395,066 | ||
| 2025-12-05 | Berman David M HEAD OF R&D | Option exercise 10b5-1 | +572 | $17.46 | $10K | 572 |
| 2025-12-05 | Berman David M HEAD OF R&D | Sale 10b5-1 | −572 | $40.14 | $23K | 0 |
| 2025-12-05 | Berman David M HEAD OF R&D | Option exercise · Employee Share Option (Right to Buy) 10b5-1 | −572 | 11,832 | ||
| 2025-12-04 | Berman David M HEAD OF R&D | Option exercise 10b5-1 | +31,341 | $17.46 | $547K | 31,341 |
| 2025-12-04 | Berman David M HEAD OF R&D | Sale 10b5-1 | −31,341 | $40.26 | $1.3M | 0 |
| 2025-12-04 | Berman David M HEAD OF R&D | Option exercise · Employee Share Option (Right to Buy) 10b5-1 | −31,341 | 12,404 | ||
| 2025-11-28 | Berman David M HEAD OF R&D | Option exercise 10b5-1 | +5,521 | $17.46 | $96K | 5,521 |
| 2025-11-28 | Berman David M HEAD OF R&D | Sale 10b5-1 | −5,521 | $40.09 | $221K | 0 |
| 2025-11-28 | Berman David M HEAD OF R&D | Option exercise · Employee Share Option (Right to Buy) 10b5-1 | −5,521 | 43,745 | ||
| 2025-11-26 | Berman David M HEAD OF R&D | Option exercise 10b5-1 | +69,404 | $17.46 | $1.2M | 69,404 |
| 2025-11-26 | Berman David M HEAD OF R&D | Sale 10b5-1 | −69,404 | $40.12 | $2.8M | 0 |
| 2025-11-26 | Berman David M HEAD OF R&D | Option exercise · Employee Share Option (Right to Buy) 10b5-1 | −69,404 | 49,266 | ||
| 2025-11-25 | Berman David M HEAD OF R&D | Option exercise 10b5-1 | +18,020 | $17.46 | $315K | 18,020 |
| 2025-11-25 | Berman David M HEAD OF R&D | Sale 10b5-1 | −18,020 | $40.03 | $721K | 0 |
| 2025-11-25 | Berman David M HEAD OF R&D | Option exercise · Employee Share Option (Right to Buy) 10b5-1 | −18,020 | 118,670 | ||
| 2025-11-24 | Berman David M HEAD OF R&D | Option exercise 10b5-1 | +100 | $17.46 | $2K | 100 |
Page 2 of 6 · 118 trades